View Older Stories View More Recent Stories
-
ASV Holdings, Inc. Prices Initial Public Offering of Common Stock
-
SMART Global Holdings, Inc. Announces Launch of Its Initial Public Offering
-
Roth Capital Downgrades QuickLogic (QUIK) to Neutral
-
2017 Louisiana Energy Conference to Be Held in New Orleans May 30 – June 2
-
Roth Capital Downgrades The Hackett Group (HCKT) to Neutral
-
UPDATE: American Superconductor (AMSC) Prices 4M Share Common Offering at $4/Sh
-
AMSC Prices $16 Million Public Offering of Common Stock
-
Roth Capital Downgrades ID Systems (IDSY) to Neutral
-
Roth Capital Upgrades Ameresco (AMRC) to Buy
-
Roth Capital Downgrades Etsy (ETSY) to Neutral
-
Roth Capital Reiterates Buy on First Solar (FSLR) Following 1Q Beat
-
SMART Global Holdings, Inc. Files Registration Statement for Proposed Initial Public Offering
-
BioPharmX Announces Closing of $5.0 Million Offering
-
Roth Capital Downgrades Mellanox Technologies (MLNX) to Neutral
-
ROTH Capital Partners Announces the Addition of Eric B. Cheng, Managing Director, Head of Healthcare Investment Banking
-
BioPharmX (BPMX) Announces $5M Offering of Common Stock and Warrants
-
BioPharmX Announces $5.0 Million Offering
-
2017 Q1 PIPEs Market Eclipses Last Year's First Quarter
-
Roth Capital Starts Zafgen (ZFGN) at Buy
-
Roth Capital Starts Mateon Therapeutics (MATN) at Buy
-
Sorrento Announces Closing of Public Offering of Common Stock
-
Roth Capital Reiterates Buy Rating and $17 PT on Renewable Energy Group (REGI); 'ITC Conference Gives Confidence in Positive Outcome for Anti-Dumping Case'
-
Clean Diesel Technologies (CDTI) PT Raised to $2.50 at Roth Capital; '2018 Revenue Cliff Approaching'
-
Sorrento Therapeutics (SRNE) Prices 23.63M Common Stock Offering at $2/Share
-
Sorrento Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Auris Medical Holding AG (EARS) at Buy
-
PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
-
Roth Capital Reiterates Neutral Rating and $6 PT on Maxwell Technologies (MXWL); 'Strategic Investment Should Lower L-T Risks'
-
Roth Capital Reiterates Buy Rating and $11 PT on Hydrogenics (HYGS) Following News of $1.6M Toronto Hydrogen Project Selection
-
AIT Therapeutics Inc. Raises Gross Proceeds of $10.9 Million and Completes Reverse Merger
-
Moleculin Biotech, Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
-
Roth Capital Assumes SenesTech (SNES) at Buy
-
Roth Capital Upgrades Digital Turbine (APPS) to Buy
-
4th Annual ROTH China Solar Tour to be Held in Conjunction with SNEC Power Expo in Shanghai April 18-21, 2017
-
Roth Capital Reiterates Sell Rating and $150 PT on Acuity Brands (AYI); 'Survey Points to Likely F2Q17 Miss'
-
Cree (CREE) PT Lowered to $33 at Roth Capital Following Survey
-
Roth Capital Reiterates Buy on Revolution Lighting (RVLT) Following Survey
-
Biocept (BIOC) to Sell 4.32M Shares at $2.15 with Warrants
-
Biocept Announces Pricing of $9.3 Million Financing
-
First Solar (FSLR) PT Lowered to $29 at Roth Capital Following Mgmt Meetings; 'N-T Earnings Challenges Ahead'
-
Sphere 3D Announces Registered Direct Equity Offering and Concurrent Private Placement
-
Valeritas Announces Pricing of $52.5 Million Public Offering of Common Stock
-
Oppenheimer & Co. Inc. Expands Its Healthcare Investment Banking by Adding a Leading Life Sciences Team
-
Himax Technologies (HIMX) Gains 5% Amid Roth Capital Upgrade
-
Roth Capital Upgrades Himax Technologies (HIMX) to Buy
-
Brosh Capital Requests Extraordinary General Meeting at Alcobra (ADHD), Seeks to Remove Board in Full
-
Brosh Capital Delivers Extraordinary General Meeting Request To Alcobra And Issues Letter To Chairman
-
TipRanks Identifies the Top 10 Analysts of 2016
-
MeetMe Closes Public Offering of 9,200,000 Shares of Common Stock
-
New Age Beverages Corporation To Webcast Presentation at ROTH Capital Partners Conference Today, March 15, 2017

